INTRODUCTION
Pur-alpha (Pura) is a sequence-specific single-stranded DNA and RNA-binding protein (1, 2) . Highly conserved throughout evolution, the sequence of mouse Pura differs from the sequence of human Pura in only 2 out of 322 amino acid residues (2) . A variety of potential functions have been described for Pura, ranging from the initiation of DNA replication and gene transcription to the compartmentalized mRNA translation (3 -5) . Furthermore, Pura affects cell cycle regulation and has been linked to oncogenic transformations (6 -9) . Although the Pura protein is expressed in every metazoan tissue (4) , its regulatory function appears to be tissue-specific, and it seems to be primarily active during development (10, 11) . In the brain, its exact function is still controversial, but most likely it is involved both in neuronal proliferation and in the maturation of dendrites. Mice with targeted disruption of the Pura gene in both alleles appear normal at birth, but at 2 weeks of age, they develop neurological deficits and die within 4 weeks (12) .
Fragile X-associated tremor/ataxia syndrome (FXTAS) is a recently discovered neurodegenerative disorder that affects adult carriers of permutation alleles (55-200 CGG repeats) of the fragile X mental retardation 1 (FMR1) gene (13, 14) .
Pura was shown to bind specifically to CGG repeats, and in Drosophila, the overexpression of Pura has been demonstrated to suppress rCGG-mediated neurodegeneration in a dose-dependent manner (15) .
In order to better understand the role of Pura in postnatal brain development, in the dendrite and axon formation and in the context of the FXTAS, we generated Pura-deficient mice, which we were able to raise up to the age of 6 months. This Pura knock-out mouse model allowed us to study the function of Pura through phenotype analysis and to describe the impact of Pura on brain growth and on hippocampal and cerebellar development throughout the postnatal period. Importantly, it was now, for the first time, possible to document the consequences of Pura deficiency for postnatal brain development from newborn to adult.
RESULTS

Pura
2/2 mice were live born and did not show any phenotypical difference compared with wild-type littermates until postnatal days [12] [13] [14] [15] . At that time, Pura-deficient mice generated a severe and continuous tremor, their hind limbs appeared weak and their gait pattern was clumsy and uncoordinated. With the onset of the tremor, Pura KO mice started to lose weight and many of them had to be injected with glucose once or more during postnatal days 12 -20 in order to be kept alive. After surviving this critical phase, Pura 2/2 mice started to regain weight, which increased continuously until shortly before death. The oldest Pura 2/2 mice reached an age of 5 -6 months, still persistently shaking. The brain of 2-month-old Pura 2/2 mice was strikingly enlarged and heavier compared with wild-type littermates Proportionate hypertrophy of adult Pura 2/2 mouse cerebrum and cerebellum
The enlargement of the brain in adult Pura-deficient mice is clearly visible in histopathological sections ( Fig. 1A and C) . In the cerebrum, using Nissl-and HE-stained sections, we analyzed the cell density in the cortex and the thickness of the cortical layers at postnatal days 20 and 150. No differences in the zonal arrangement of wild-type and Pura 2/2 mice Figure 1 . Proportionate hypertrophy of the Pura 2/2 mouse brain. (A and C) HE-stained sections of adult wild-type and Pura 2/2 mouse brain. (B and D) Nisslstained sections of d150 wild-type and Pura 2/2 mouse brain cortex, I-VI marking the cortical layers. (E) The brain weight of adult Pura-deficient mice is significantly higher than that of the wild-type mice (P , 0.001) and Pura heterozygous mice (P ¼ 0.004). (F) Neither in d20 nor in adult Pura 2/2 mice did the cell density in the cortex differ from that of the Pura +/+ mice (d20: P ¼ 0.663; adult:
The hypertrophy of the Pura-deficient mouse brain is proportional. Stratum lacunosum (SL) and the stratum moleculare of the dentate gyrus (SM1 and SM2) are significantly enlarged (SL: P , 0.001; SM1: P ¼ 0.015; SM2: P , 0.001). Scale bars: (A and C): 1 mm; (B and D): 50 mm.
474
Human Molecular Genetics, 2012, Vol. Because of the continuous tremor, which the Pura-deficient mice display, we analyzed the architecture of the cerebellum and the Purkinje cell morphology and density. No histomorphological abnormalities could be observed in the Pura 2/2 cerebellum. In order to compare the Purkinje cell number between the genotypes, sections were immunolabeled for calbindin and parvalbumin. At postnatal days 10 and 20, Pura 2/2 mice and wild-type mice did not show any differences in the density (Purkinje cells/1 mm line length) and arrangement of the Purkinje cells [ Fig. 2A and B; d10 (MannWhitney -Wilcoxon, MWW): WT: 32.8, KO: 32.7, P ¼ 0.93; d20: WT: 26.1 + 2.0, KO: 24.3 + 0.9; P ¼ 0.384]. In adult mice (d150), the number of Purkinje cells was significantly higher in wild-type mice than in mice lacking Pura ( Fig. 2E -G ; WT: 23.8 + 1.4, KO: 18.9 + 0.9; P ¼ 0.019), but the size and the shape of the Purkinje cells did not differ. The bigger branches of the dendritic arbor of d20 and d150 Pura 2/2 mouse Purkinje cells were similar to those of the wild-type mice Purkinje cell dendrites, no obvious difference could be seen ( Fig. 2C and D) .
Since Pura has been identified to play a decisive role in DNA replication (3, 4) and postnatal development (12, 16) , and we now observed a megalencephaly in Pura 2/2 mice, we analyzed the cell proliferation in Pura 2/2 , Pura +/2 and wildtype mice at postnatal days 5, 10, 15 and 20. Histopathological analysis was performed on sections of paraformaldehydeperfused brains. We used four different markers with specificity in different cell cycle phases for the evaluation of the proliferation in the hippocampus and cerebellum: 5-bromo-2-deoxyuridine (BrdU), a thymidine analogon that is incorporated into DNA during the S-phase of the cell cycle (17); Ki67, a nuclear antigen which is expressed in all cell cycle phases except for G 0 (18, 19) ; the proliferating cell nuclear antigen PCNA, a non-histone protein associated with the DNA polymerase (20) , and the phosphorylated-histone H3 (pH3), a marker for G2/M of the cell cycle (21) .
Proliferation in the hippocampus. At postnatal day 5, BrdU, Ki67, PCNA and pH3 immunoreactivities were detected in the granule cell layer of the dentate gyrus in the hippocampus of both wild-type and Pura 2/2 mice ( Fig. 3A and B (Fig. 3G) . In contrast, in d20 Pura 2/2 mice, still several Ki67-, PCNA-, BrdU-and pH3-stained cells could be detected in the granule cell layer (Fig. 3H) .
In heterozygous Pura mutant mice, the numbers of BrdU-, Ki67-, PCNA-and pH3-positive cells were situated between those of Pura 2/2 and wild-type littermates at each postnatal age examined (data not shown).
Proliferation in the cerebellum. In the cerebellum, we analyzed the BrdU/ Ki67/ PCNA/pH3 immunoreactivity in the external granule layer (EGL). At postnatal day 5, both wild-type and Pura 2/2 mice exhibited an intensive BrdU/ Ki67/PCNA/pH3 staining ( Fig. 3J and K) . The number of Ki67-labeled cells per 100 cells was elevated in d5 Pura 2/2 cerebella compared with age-matched wild-type littermates ( Fig. 3R ; MWW: WT: 93.0, KO: 96.2, P ¼ 0.003). PCNA-, BrdU-and pH3-stained sections were intensively labeled in both wild-type and Pura-deficient mice; the statistical analysis did not reveal a significant difference. At postnatal day 10, the comparison of the EGL of wild-type and Pura 2/2 mice revealed striking differences: Pura 2/2 mice showed significantly higher numbers of all BrdU/Ki67/PCNA/pH3-labeled cells compared with wild-type littermates [ Fig In contrast, Pura 2/2 mice still displayed one to two layers of granule cells in the EGL at postnatal day 20, within which PCNA-, pH3-, Ki67-and BrdU-stained cells could be detected ( Fig. 3P and Q) .
Similar to the data obtained in the hippocampus, quantitative analysis of the number of Ki67/PCNA/BrdU/pH3-stained cells of heterozygous Pura mutant mice in the cerebellum revealed values in between those of Pura 2/2 and wild-type mice at all postnatal stages analyzed (data not shown).
In order to address the question whether enhanced proliferation in Pura 2/2 mice results in an increased number of postmitotic neurons, we counted the total number of granule cells in an area of 10 000 mm 2 of the lamina granularis of the dentate gyrus and in an area of 22 000 mm 2 in the IGL in the cerebellum of wild-type and Pura 2/2 mice. Analysis was performed at postnatal days 5, 10 and 15 in the dentate gyrus and at postnatal days 15, 20 and in adult mice in the cerebellum.
In the dentate gyrus at postnatal day 5, the number of granule cells was significantly lower in Pura 2/2 mice compared with wild-type littermates ( In order to analyze whether the higher proliferation rates of neuronal precursor cells in Pura-deficient mice are compensated with an increased neuronal cell death, we stained sections of d5, d10, d15 and d20 Pura 2/2 and wild-type mice hippocampus and cerebellum for active caspase 3. In the hippocampus, the positive cells were counted in the granule cell layer of the dentate gyrus; in the cerebellum, positive cells were counted in the external and IGL per visual field at a magnification of 100×. Here we did not observe significant differences between wild-type and Pura-deficient mice at any postnatal time point analyzed, neither in the granule cell layer of the dentate gyrus nor in the granule cell layers of the cerebellum (hippocampus: d5: WT: 0. 
MAP2 reduction in Pura 2/2 mice
The microtubule-associated protein MAP2 is a cytoskeletal protein localized highly preferentially in the neuronal dendritic compartment and is considered to be a dendritic marker 
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Human Molecular Genetics, 2012, Vol. 21, No. 3 (22, 23) . MAP2 immunostaining in the cortex of adult wildtype mice revealed staining of dendrites while the cell bodies reacted weaker (Fig. 5A) . On the contrary, Pura
mice showed remarkably less MAP2-stained dendrites in the cortex (Fig. 5B) . Striking was not only the loss of the MAP2-stanining in the Pura mutant mice, but also the misdistribution of MAP2 within the cell: the somata were much more intensively labeled than the dendrites (Fig. 5B, arrows) . A similar mislocation of MAP2 was observed in the hippocampal CA1/CA2 region of the Pura 2/2 mice. The proliferation was significantly enhanced in the hippocampus of Pura-deficient mice at d5 stained with BrdU (P ¼ 0.008), Ki67 (P ¼ 0.007) and PCNA (P ¼ 0.029) and at d10 stained with BrdU (P ¼ 0.040). (R) The proliferation rates in the cerebellum of Pura 2/2 mice were significantly higher at d5 for Ki67 (P ¼ 0.003), at d10 for BrdU (P , 0.001), Ki67 (P ¼ 0.005), PCNA (P , 0.001) and pH3 (P ¼ 0.031) and at d15 for BrdU (P , 0.001), Ki67 (P , 0.001) and PCNA (P ¼ 0.003). Scale bars: (A -H): 200 mm; (J-Q): 100 mm.
In the cerebellum of adult wild-type mice, MAP2 immunoreactivity was characterized by intense labeling of Purkinje cell dendrites, whereas Purkinje cell bodies were only faintly stained (Fig. 5C ). In contrast, MAP2 staining of Purkinje cell dendrites in adult Pura 2/2 mice was diminished. Analogous to the findings in the cerebral cortex of Pura mutant mice, MAP2 was misdistributed in the cerebellum, too: many of the Purkinje cell bodies reacted strongly with the MAP2 antibodies (Fig. 5D, arrows) . Such an intensive staining of the somata could not be observed in the Purkinje cells of Pura +/+ mice; in the wild-type littermates, the Purkinje cells were always only faintly stained. Overall, the immunohistochemical analysis of MAP2 expression in adult wild-type and Pura 2/2 cerebra and cerebella suggests an altered distribution of MAP2 expression in Pura-deficient animals with reduced expression in dendrites and enhanced expression in the neuronal cell somata. Moreover, the expression intensity seemed to be reduced in Pura 2/2 mice. To confirm these findings, western blot analysis of whole brain lysates was performed. Both d10 and d20 Pura mutant mice showed significantly lower MAP2 levels compared with d10 and d20 Pura +/+ littermates (d10: WT: 87.0 + 7.1, KO: 38.7 + 4.5, The intensities of the resulting bands were quantified using the Fuji LAS3000 mini system: the amount of MAP2 in Pura-deficient mice was significantly reduced at d10 (P ¼ 0.004), d20 (P ¼ 0.041) and d42 (P , 0.001). Scale bars: (A-D): 100 mm.
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Human (24, 25) . NFs are heteropolymers composed of three kinds of subunits, high (NF-H), middle (NF-M) and low (NF-L) molecular weight NF proteins. In neurodegenerative disorders, NFs are known to be hyperphosphorylated (26) . For immunostaining, the antibodies SMI32, specific for non-phosphorylated NF epitopes, and SMI31, specific for phosphorylation-dependent NF epitopes, were used. Normally, the phosphorylated NF-H/M epitopes (SMI31) are found in axons, whereas the nerve cell bodies are generally non-reactive (27) . Consistent with the expected localization, SMI31 primarily stained axon tracks throughout the brain of wild-type mice ( Fig. 6A and C) . Pura 2/2 mice showed a remarkable increase in axonal staining with SMI31 in the cerebral cortex compared with wild-type littermates (Fig. 6B and D) . Furthermore, the SMI31-stained NFs were misdistributed in Pura 2/2 mice: the reaction with SMI31 could be found not only in axons, but also in neuronal cell somata (Fig. 6D, arrowheads) and dendrites (Fig. 6D, arrows) . Non-phosphorylated NF-H epitopes (SMI32) are primarily located in somatodendritic compartments and thick axons (28) . In the cortex of adult wild-type mice, axons and cell somata were slightly stained with SMI32 antibodies (Fig. 6E and G) . Pura-deficient mice showed much stronger immunoreactivity for SMI32 in the cerebrum (Fig. 6F) . Remarkable was the intensive staining of neuronal somata (Fig. 6H , arrowheads) and dendrites (Fig. 6H, arrows) in the cortex of Pura 2/2 mice. In the cerebellum of Pura 2/2 mice, the findings of impaired axonal protein distribution were not as obvious and consistent.
To quantify these histological abnormalities, immunoblotting was performed on whole brain lysates of wild-type and Pura mutant mice on postnatal days d20, d42 and d150. No significant increase in SMI31 immunoreactivity in d42 and d150 Pura 2/2 mice could be seen compared with wild-type mice [d42 (MWW): WT: 100.0, KO: 120.2, P ¼ 0.690; d150 (MWW): WT: 100.0, KO: 94.4, P ¼ 1.0]. SMI32 immunoreactivity showed a tendency to be lower in d20 and d42 Pura 2/2 mice than in age-matched wild-type littermates, but the differences were not significant [d20 (MWW): WT: 100.0, KO: 87.24, P ¼ 0.065; d42 (MWW): WT: 100.0, KO: 72.5, P ¼ 0.333]. On d150 mice the SMI32 antibody displayed slightly elevated immunoreactivity in Pura 2/2 mice compared with wild-type mice, but again the difference was not significant [d150 (MWW): WT: 100.0, KO: 134.6, P ¼ 0.10].
In order to estimate whether the altered localization and hyperphosphorylation of NFs in Pura 2/2 mice affects the shape of axons in the cerebral cortex, we performed silver staining. As shown in Figure 6I and J, Pura 2/2 mice displayed striking axonal aberrations, whereas axonal organization of wild-type mice appeared normal. 
DISCUSSION
A transgenic mouse model with inactivated Pura gene has previously revealed first evidence that Pura plays an essential role in postnatal brain development (12) . Phenotypically, we obtained very similar findings in independently generated knockout mice. Pura 2/2 mice appeared normal at birth. At the age of 2 weeks however, they developed neurological symptoms such as continuous and increasingly severe tremor. Furthermore, Pura 2/2 mice could not walk normally: they showed a gait pattern that was clumsy and uncoordinated, and their hind limbs appeared weak. Pura mutant mice did not gain weight normally after the tremor onset and, if not injected with glucose, died of starvation by postnatal day 25. Histopathological analysis of the brain of our Pura 2/2 mice revealed striking differences in comparison to the previous study. Khalili et al. (12) reported a severe reduction in the proliferation of neuronal precursor cells at postnatal days 5, 10 and 19 in the Pura-deficient mice, whereas we observed a significant enhancement of proliferation at these stages. To clarify these ambivalent findings, we performed an immunohistochemical study using various cell cycle markers. Contrary to the findings of Khalili et al., significantly enhanced proliferation rates were observed both in Pura 2/2 hippocampi and cerebella during defined stages of early postnatal development. We never found a decreased proliferation rate in Pura 2/2 mice when compared with wild-type animals, as it was described by Khalili et al. Since the numbers of hippocampal and cerebellar granule cells in adult Pura 2/2 and Pura +/+ mice were equal, and the higher proliferation rates of neuronal precursor cells in Pura-deficient were not compensated with an increased neuronal cell death, we conclude that the increased proliferation rates of the Pura 2/2 mice may reflect a protraction of the brain development. These findings fit very well to the proposed role which Pura is thought to have in controlling cellular proliferation: Pura has been identified to bind different cellular regulatory proteins including the retinoblastoma protein (29), E2F-1 (30,31), YB-1 (32), Sp1 (33) and cyclin A/Cdk2 (34). Stacey et al. (6) reported that microinjected Pura can block the G1-S transition, and Barr and Johnson (7) observed that Pura significantly inhibits colony formation by ras-transformed cells. Pura has been linked to several types of cancer: Lezon-Geyda et al. (8) showed that Pura can suppress glioblastoma cell growth. Overall, previous publications showed that ectopic overexpression of Pura leads to the inhibition of DNA replication and cell cycle progression and that loss of Pura is observed in different types of cancer. In conclusion, one would expect the deletion of Pura to cause enhanced proliferation, just as it was observed in our Puradeficient mice.
Similar to the data on neuronal proliferation during postnatal brain development, we could not reproduce the morphological abnormalities, which Khalili et al. (12) described in their Pura 2/2 mice, such as a reduced neuronal number both in the cerebral cortex and in the cerebellar granule cell layer, disorganized cortical layers and smaller size and numbers of Purkinje cells. We did not find any significant differences in the organization of the cerebral cortex or the cerebellum. Also the numbers of Purkinje cells as well as their branching was not different form littermate controls at all stages of postnatal brain development analyzed. In adult Pura 2/2 mice, we observed, however, striking brain hypertrophy, visible to naked eye. This hypertrophy appeared proportionally in various brain regions like in the cerebral cortex, hippocampus, thalamus as well as the brain stem. Detailed histological analysis of the adult mouse brain did not reveal any significant differences in the neuronal cell density or in the organization of the cerebral cortex between Pura mutants and littermate controls. Only the Purkinje cell density was slightly reduced in the adult Pura 2/2 mouse cerebellum, which may, however, be due to the cerebellar hypertrophy.
Since many of the histopathological analyses performed by Khalili et al. (12) were not implemented at different developmental stages, a few of their findings, e.g. the diminished number of granular cells in the cerebellum, could be thought to be in accordance with our finding of the developmental delay in Pura 2/2 mice (Fig. 4) . However, for the most part, we do not have a conclusive explanation for the discrepancies between this present study and the previous one (12) . The methods and software used by Khalili and colleagues to quantify cell numbers in the cerebral cortex, hippocampus and cerebellum are not described. Their studies on cellular proliferation are limited to the presentation of the results obtained with one marker (MCM7). Moreover, the number of mice analyzed per age group is stated neither for immunhistochemistry nor for immunoblotting studies.
The only histological observation that is in line with results obtained by Khalili et al. (12) and Johnson et al. (5) is a significant reduction in the expression of the dendritic protein MAP2. This was obvious by immunohistochemistry as well as quantitative western blot analysis both during postnatal development and in adult Pura 2/2 mice. Furthermore, we observed an alteration in the cellular distribution of MAP2 that has not been described previously: MAP2 was found to accumulate in the neuronal cell somata both in the cerebral cortex and in the cerebellum in Pura-deficient mice. How do these observations relate to the lack of Pura? It is well known that MAP2 mRNA is transported from neuronal cell bodies into dendrites for translation by cytoskeletal-dependent and developmentally regulated mechanisms (37 -40) . In addition to mRNAs, untranslated RNAs with important roles in the regulation of the translation are localized in dendrites. These include the brain-specific non-coding BC1 RNA (41), which is reported to be a specific effector of translational control in synapto-dendritic domains (42, 43) . It has been shown that Pura binds to the BC1 RNA, acts as an activator for BC1 RNA transcription and links the BC1 RNA to microtubules (44, 45) . Interestingly, BC1 is detected also in axons, co-localizing with axonal mRNAs (46) (47) (48) . Both the dendritic and the axonal transport of BC1 RNA are dependent on the integrity of microtubules (48, 49) . Johnson et al. (5) have demonstrated that BC1 RNA and MAP2 mRNA are associated with Pura. Thus, it is conceivable that Pura influences the MAP2 mRNA translation through BC1 RNA. It has also been suggested that Pura may affect the expression of MAP2 through its direct association with MAP2 mRNA (5). The reduced and altered expression of MAP2 of Pura-deficient mice observed in the present study supports the notion that Pura has an important role in the distribution of MAP2. However, whether this is directly related to the lack of Pura as proposed by Johnson et al. (5), or indirectly due to an altered function of BC1 as a result of the lack of Pura, remains an open question. Since mice with eliminated BC1 did not show any pathological phenotype compared with wildtype mice, and did not reveal any alterations in MAP2 expression and distribution (50) , it seems yet unlikely that a lack of BC1 function explains the Pura 2/2 phenotype we observed. The FXTAS is a late-onset neurodegenerative disorder that affects carriers of the fragile X permutation with fragile X mental retardation 1 (FMR1) gene containing 55 -200 CGG repeats (13, 14) . An expansion over 200 CGG repeats leads to the fragile X syndrome (FXS) (51) . Pura is identified to be a part of an mRNP complex and to interact with multiple proteins, including FMRP, the protein encoded by FMR1 gene (52) . Furthermore, Pura binds specifically to CGG repeats both in vitro and in vivo, and the overexpression of Pura is shown to suppress CGG-mediated neurodegeneration in a dose-dependent manner in Drosophila (15) . In consideration of these findings, it seems likely that Pura influences the pathogenesis of the FXTAS. In fact, the phenotype of the adult Pura mutant mice remarkably resembles the clinical signs of the FXTAS, which are, amongst others, gait ataxia and intention tremor (53) . Megalencephaly is not described in FXTAS patients, but is a possible clinical feature of FXS patients (54) . The role of Pura in the pathogenesis of the FXTAS, reasons for the Pura 2/2 mice macroencephaly and a possible connection of Pura with macrocephaly syndromes still have to be explored.
In summary, the key findings of this study indicate that the loss of Pura leads to a prolongation of neuronal precursor cell proliferation during postnatal development, a reduced expression of MAP2 and pathological hyperphosphorylation of axonal proteins. Moreover, in adult Pura-deficient mice, a phenotype with continuous tremor, ataxia and enlarged brain size was observed for the first time, resembling phenotypical aspects of the FXTAS. This new Pura knockout mouse model will provide deeper insight into the function of Pura and its potential role in the development of neurodegenerative diseases.
MATERIALS AND METHODS
Generation of the Pura knockout mice
Pura knock-out mice were generated by replacing the complete open-reading frame of the Pura gene and about 1.8 kb of 3 ′ -flanking sequences by the selection marker neomycin by homologous recombination in embryonic stem cells derived from mouse strain 129/Ola.
To generate the Pura-targeting vector, a 1.2 kb fragment 5 ′ of the start codon of the Pura gene and a 7.0 kb fragment 3 ′ of the open-reading frame were amplified by PCR from genomic DNA of 129/Ola ES cells. The fragments were cloned into the plasmid pKO Scrambler V920 (Lexicon Genetics Incorporated) separated by the PGK-Neo cassette (isolated from the plasmid pKO SelectNeo, Lexicon Genetics Incorporated). The pMC1-TK cassette (isolated from the plasmid pKO SelectTK, Lexicon Genetics Incorporated) was cloned adjacent to the 7.0 kb fragment.
The targeting vector was linearized and electroporated into E14 mouse embryonic stem cells. After geneticin (G418) and gancyclovir selection, resistant clones were analyzed by PCR and Southern blot analyses to identify clones where a correct homologous targeting event had replaced the Pura openreading frame by the PGK-Neo cassette.
For PCR screening, ES cells were lysed using Kawasaki buffer, and PCR reactions were performed using primer P11M1 (5 ′ -CGTACGCCCGGGGCTCTCATTGATACTTGC TAATTTTCTGGG-3 ′ ) and Neo-primer (5 ′ -GGATGCGGT GGGCTCTATGGCTTCTGAGG-3 ′ ). In correctly targeted cells, this PCR reaction yielded a 1.2 kb fragment, whereas no fragment was amplified in wild-type cells, or in cells with random integration of the targeting vector.
Clones positive in the PCR screening were verified by Southern blot analysis; 10-15 mg of genomic DNA was digested with BamH1, separated on a 0.8% agarose gel and transferred to a nylon membrane (Hybond-N, Amersham). The blots were hybridized with a 5
′ external probe (a 500 bp XhoI/EcoRV fragment), a 3
′ external probe (a 400 bp HindIII/BamHI fragment) and a Neo-probe (a 400 bp SphI fragment) to identify the correctly targeted clones.
PCR screening and Southern blot analysis confirmed ES clone 248 to be the sole clone out of 2400 ES clones tested to contain the mutated Pura locus.
ES clone 248 was injected into blastocysts (BALB/c) yielding eight chimeras with 30-95% coat color chimerism. To generate Pura +/2 animals, chimeras were bred among each other or with wild-type BALB/c mice. Pura +/2 animals were identified by Southern blot analysis.
To simplify the detection of heterozygous and homozygous Pura mutant animals, a PCR method was established. A pair of Neo-primers (Neo2a: 5 ′ -GATCTCCTGTCATCTCACC TTGC-3 ′ and Neo2b: 5 ′ -TGGCAACTAGAAGGCACAGTC G-3 ′ ) and a pair of Pura primers (HeM4: 5 ′ -ctaggtcgac CGGCTCCTCCTCCAC-3 ′ and HeM5: 5 ′ -tacggaattcatgGT GGAGTTCCGCGAC-3 ′ ) from exon II were designed to amplify a 450 bp Neo fragment and a 349 bp Pura fragment, respectively. Neo-primers yield their specific product from genomic DNA of Pura +/2 and Pura -/2 animals, but no product with Pura +/+ animals. Pura primers yield a product with Pura +/+ and Pura +/2 animals but none with Pura 2/2 animals, thereby allowing to distinguish between wild-type mice and heterozygous and homozygous Pura mutant animals.
Antibodies
Antibodies against BrdU, Calbindin, Caspase3, Ki67, MAP2, Parvalbumin, PCNA, pH3, SMI31 and SMI32 used in immunoblotting and immunohistochemical studies are listed in Table 1 .
Immunoblotting
Brain protein extracts were prepared as described in Bu et al. (26) . For all age groups, Pura +/+ (n ¼ 3), Pura +/2 (n ¼ 3) and Pura 2/2 (n ¼ 3) mice were quantified. For protease inhibition, complete protease inhibitor cocktail tablets (Roche) were used (one tablet in a 5 ml buffer). Homogenates were centrifuged at 12 000g for 15 min. The protein content in supernatants was measured using Bio-Rad protein assay kit and the supernatant was frozen at 2808C for storage; 10 mg of protein samples per lane was electrophoresed on 10% SDS -PAGE gels and transferred to PVDF membranes. Membranes were dried at room temperature (RT) for 30 min and blocked in 5% milk in TBST for 1 h. Blots were incubated overnight at 48C with antibodies diluted in 5% milk in TBST as shown in Table 1 . Blots were washed four times in TBST for 5 min and incubated with subtype-specific secondary antibodies conjugated to HRP for 1 h. Blots were washed again four times in TBST for 5 min. For ECL detection, SuperSignal West Dura Extended Duration Substrate (Thermo Scientific) was used. Pictures were acquired using the Fuji LAS3000 mini system. Band intensity was measured using Fuji Multi Gauge program (26) .
Immunohistochemistry
Mice at postnatal ages d5 (Pura +/+ , n ¼ 9; Pura +/2 , n ¼ 6;
, n ¼ 4) and d140-180 (Pura +/+ , n ¼ 5; Pura +/2 , n ¼ 6; Pura 2/2 , n ¼ 4) received an overdose of 5% isoflurane anesthesia before removing the brain. Brains were fixed overnight in 4% paraformaldehyde in phosphate buffer (pH 7.4) and transferred into paraformaldehydephosphate-buffered saline (PBS) solution -0.02% sodium azide at 48C. Brain halves were embedded in paraffin for hematoxylin and eosin staining and for immunohistochemical procedure.
Immunohistochemistry was performed on 4 mm thick sagittal sections using the alkaline phosphatase -anti-alkaline phosphatase technique (APAAP; DAKO, Glostrup, Denmark). Antibodies against PCNA, pH3, Ki67, Calbindin, Parvalbumin, SMI31, SMI32, MAP2, T46 and PHF-1 (Table 1) diluted in PBS were applied on sections for 2 h at RT. Sections were then washed and incubated with the secondary antibody (rabbit-anti mouse IgG; DAKO; 1: 50 in PBS) for 45 min at RT, and the APAAP complex was used for detection (mouse monoclonal, 1: 40 in PBS). Alkaline phosphatase activity was visualized with Astraneufuchsin (Sigma-Aldrich, Taufkirchen, Germany). All sections were counterstained with haemalaun and dehydrated and embedded with Aquamount (BDH Laboratory Supplies, UK).
BrdU labeling
We employed BrdU (Roche Diagnostics), a thymidine analogon that is incorporated into DNA during the S-phase of the mitotic process, as a proliferation marker in this study. Wildtype, heterozygous and homozygous Pura mutant mice of postnatal ages d5 (Pura +/+ , n ¼ 3; Pura +/2 , n ¼ 3; Pura 2/2 , n ¼ 3), d10 (Pura +/+ , n ¼ 5; Pura +/2 , n ¼ 5; Pura 2/2 , n ¼ 4), d15 (Pura +/+ , n ¼ 2; Pura +/2 , n ¼ 3; Pura 2/2 , n ¼ 3) and d60-75 (Pura +/+ , n ¼ 4; Pura +/2 , n ¼ 4; Pura 2/2 , n ¼ 4) received a single intraperitoneal injection of BrdU (dose: 50 mg/kg body weight, 10 mM, dissolved in sterile PBS) 2 h before sacrifice. By measuring BrdUpositive cells 2 h after the BrdU injection, BrdU-positive cells reflect the number of cells in S-phase. Mice were anesthetized with 5% isoflurane prior to intracardial perfusion with PBS and 4% paraformaldehyde in PBS. The brains were postfixed overnight at 48C with 4% paraformaldehyde and stored at 48C in PBS -0.02% sodium azide until processed for immunohistochemistry.
Formalin-fixed, paraffin-embedded brain halves were cut in 4 mm thick sagittal sections, cleared of paraffin and blocked with 0.3% H 2 O 2 in 50% methanol for 20 min. Sections were incubated with pepsin solution (Boehringer, Mannheim, Germany, 0.4 mg/ml in 0.1 N HCl) for 30 min at RT, rinsed in PBS, incubated in 2 N HCl for 30 min at 378C, rinsed in 0.1 M Na 2 B 4 O 7 , pH 8.5, 2 × 5 min, rinsed in PBS, incubated in 100 ml of diluted peroxidase-conjugated rabbit -anti-mouse Ig for 60 min at RT, rinsed in PBS and incubated in diaminobenzidine (DAB) solution (0.5 mg/ml 3.3 DAB and 0.01% H 2 O 2 in 0.05 M Tris -HCl) pH 7.6 for 10 min. Sections were counterstained with haemalaun and dehydrated and embedded with Aquamount (BDH Laboratory Supplies, UK). Cells with dense staining of more than half of the nucleus were considered BrdU-positive.
Microscopic analysis and quantification
Images were collected on an Olympus (Tokyo, Japan) BX50 microscope equipped with a Color View IIIu CCD camera (Soft Imaging System). Microscopic analysis and quantification were performed using the imaging software Cell (Soft Imaging Systems), and figures were assembled using Photoshop (Adobe).
Statistical analysis
All results are expressed as mean + SEM. Statistical significance of differences between two groups was evaluated using Student's t-tests (two-tailed). One-sample t-tests (twotailed) were used to determine whether data sets that were normalized to matched control values were significantly different from 100%. When data sets were not normally distributed, a non-parametric MWW rank-sum test was applied to compare the two groups. Statistical significance is defined as P , 0.05.
